| Dance/Movement Therapy for Bone Mineral Density in Schizophrenia (NCT05716802) | Hebei Province Veterans Hospital | 2020-07-07 |
| Lifestyle Redesign For Schizophrenia (NCT04430868) | Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan | 2020-07-01 |
| Self and Body-esteem in Socio-professional Rehabilitation (NCT04436757) | Hôpital le Vinatier | 2020-06-22 |
| Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia (NCT04461119) | Newron Pharmaceuticals SPA | 2020-06-16 |
| Implementing mHealth for Schizophrenia in Community Mental Health Settings (NCT04147897) | University of Washington | 2020-06-16 |
| Online HD-tDCS Over the Left DLPFC During a Working Memory Task for Treating Negative Symptoms of Schizophrenia (NCT05582980) | Tri-Service General Hospital (TSGH) | 2020-06-15 |
| Cognitive Training for Emotion Regulation in Psychotic Disorders (NCT04414215) | University of Georgia | 2020-06-01 |
| Application of a Mindfulness and Self-Compassion Program in Patients With Schizophrenia. Randomized Controlled Trial. (NCT04144075) | Gutiérrez-Hernández, ME | 2020-05-01 |
| Using Digital Media Advertising to Reduce the Duration of Untreated Psychosis (NCT03975400) | Northwell Health | 2020-04-22 |
| Influence of Vitamin D Supplementation on Serum BDNF Level and Cognitive Function in Schizophrenia (NCT03284294) | Universitas Padjadjaran | 2020-04-15 |
| Using Clinical Process Indicators, Patient Reported Outcome Measures (PROMs), and Patient Reported Experience Measures (PREMs) to Improve the Quality and Continuity of Care for Psychiatric Patients (NCT04314154) | Shalvata Mental Health Center | 2020-04-15 |
| Effects of Auditory Stimulation on Sleep and Memory in Schizophrenia (NCT04783571) | Massachusetts General Hospital | 2020-04-13 |
| Safety and Efficacy of Virtual Reality Mindfulness in Patients With Psychosis (NCT05784948) | Chonbuk National University Hospital | 2020-04-08 |
| A Pilot Randomised Controlled Trial of a Health Champion Intervention (NCT04124744) | King's College London | 2020-04-02 |
| Survey on Pre-ECT Evaluation and ECT Application (NCT04335916) | Klinički Bolnički Centar Zagreb | 2020-04-01 |
| Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Japanese Male and Female Subjects With Schizophrenia (NCT04325737) | Sumitomo Pharma Co., Ltd. | 2020-03-31 |
| BXCL501 for Agitation in Schizophrenia (NCT03708315) | Yale University | 2020-03-09 |
| Goals in Focus: CBT for Motivational Negative Symptoms of Psychosis (NCT05252039) | University of Hamburg-Eppendorf | 2020-03-01 |
| DELPhI Evaluation of Psychiatric Conditions (NCT03842345) | QuantalX Neuroscience | 2020-03-01 |
| Study of CAD-9303 in Subjects With Schizophrenia (NCT04306146) | Cadent Therapeutics | 2020-02-28 |
| Models of Auditory Hallucination (NCT04210557) | Yale University | 2020-02-27 |
| Social Cognition Training and Vocational Rehabilitation (NCT04025905) | Hôpital le Vinatier | 2020-02-14 |
| Cognitive Remediation in Forensic Mental Health Care (NCT04610697) | The Royal Ottawa Mental Health Centre | 2020-02-10 |
| Assessment of the Effectiveness of the NECT Program (NCT03972735) | Hospital Center Alpes-Isère | 2020-02-10 |
| French Source-monitoring Task (NCT04237155) | Hôpital le Vinatier | 2020-02-07 |
| Cognitive Remediation Program for Family Caregivers in Schizophrenia (NCT04173598) | University Hospital, Montpellier | 2020-02-06 |
| rTMS Add on Value for Amelioration of Negative Symptoms of Schizophrenia (NCT04318977) | University of Regensburg | 2020-02-01 |
| Learning and Executive Function Disorders in Children and Psychosis Risk at Adult-age (NCT04280367) | Assistance Publique - Hôpitaux de Paris | 2020-01-28 |
| Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia (NCT04268303) | BioXcel Therapeutics Inc | 2020-01-24 |
| Rochester Forensic Assertive Community Treatment Model in Minnesota (NCT07592884) | University of Rochester | 2020-01-23 |
| Effect of Metacognitive Therapy on Negative Symptoms: a Case Series (NCT03999112) | NHS Greater Glasgow and Clyde | 2020-01-22 |
| Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults (NCT04187560) | LB Pharmaceuticals Inc. | 2020-01-22 |
| The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia (NCT04013555) | University of Maryland, Baltimore | 2020-01-20 |
| Effectiveness of a Cardiovascular Risk Intervention Program in Patients With Schizophrenia (PRISCA) (NCT04276012) | Dr. Pere Roura-Poch | 2020-01-20 |
| Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis (NCT04004416) | University of Michigan | 2020-01-16 |
| The Effects of Three Different Modalities of Exercise in Patients With Schizophrenia (NCT03953664) | Cardenal Herrera University | 2020-01-14 |
| A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia (NCT03900754) | VA Office of Research and Development | 2020-01-13 |
| Effects of Brain Stimulation on Cognition, Oscillations and GABA Levels in Schizophrenia (NCT04267003) | University of California, Davis | 2020-01-09 |
| Electroencephalogram (EEG) and Electroconvulsive Therapy(ECT) Response in Schizophrenia (NCT04220099) | Shanghai Mental Health Center | 2020-01-07 |
| Evaluation of mHealth for Serious Mental Illness (NCT04068467) | University of Washington | 2020-01-06 |
| A Safety，Tolerability and Pharmacokinetics Clinical Trial of JX11502MA Capsule (NCT05233657) | Zhejiang Jingxin Pharmaceutical Co., Ltd. | 2020-01-04 |
| Early Psychosis Intervention - Spreading Evidence-based Treatment (NCT03919760) | Centre for Addiction and Mental Health | 2020-01-03 |
| Develop a Novel Occupational Training Program for Schizophrenia Patients Based on Virtual Reality Techniques (NCT05830903) | National Taiwan University Hospital | 2020-01-01 |
| Optimal rTMS for Cognitive Deficits and Negative Symptoms in Schizophrenia (NCT05599373) | Shanghai Mental Health Center | 2020-01-01 |
| Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial (NCT04173572) | University of North Carolina, Chapel Hill | 2019-12-20 |
| Cognitive Behavioral Therapy for Insomnia (CBT-I) in Schizophrenia(SLEEPINS) (NCT04144231) | Helsinki University Central Hospital | 2019-12-19 |
| Cerebral Impact of Cognitive Remediation for People Suffering From Schizophrenia (NCT04033978) | Hôpital le Vinatier | 2019-12-17 |
| Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode (NCT04203056) | University of California, Los Angeles | 2019-12-16 |
| A Study of Cognitive Adaptation Training in Inpatient Forensic Environments (NCT04294719) | Centre for Addiction and Mental Health | 2019-12-12 |
| Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis (NCT04368039) | Nicholas Breitborde | 2019-12-04 |
| Estradiol as add-on to Antipsychotics (NCT04093518) | Tangent Data | 2019-12-02 |
| Brain Stimulation And Group Therapy to Improve Gesture and Social Skills in Psychosis (BrAGG-SoS) (NCT04106427) | University of Bern | 2019-12-01 |
| The Effect of Repetitive Transcranial Magnetic Stimulation in Schizophrenia (NCT03736291) | Shanghai Mental Health Center | 2019-12-01 |
| A Study of Staccato Loxapine (ADASUVE®) for Inhalation (NCT04148963) | Lee's Pharmaceutical Limited | 2019-12-01 |
| Effect of Hot Footbath on the Sleep Quality (NCT04703530) | National Taipei University of Nursing and Health Sciences | 2019-12-01 |
| The Effect of tDCS on Schizophrenia With Negative Symptoms (NCT03729791) | Seoul National University Hospital | 2019-12-01 |
| Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study. (NCT05074732) | Health Service Executive, Ireland | 2019-12-01 |
| Transcranial Weak Current Stimulation Treatments for Working Memory Dysfunction in Schizophrenia (NCT04637724) | Oded Meiron | 2019-11-29 |
| Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia (NCT03874494) | Otsuka Beijing Research Institute | 2019-11-27 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia (NCT04158687) | Concert Pharmaceuticals | 2019-11-26 |
| A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia. (NCT04115319) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2019-11-21 |
| A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia (NCT04109950) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2019-11-20 |
| Pragmatic Assessment and Treatment for the Health System (NCT05809401) | IRCCS San Camillo, Venezia, Italy | 2019-11-13 |
| Neurobiological Effects of Oxytocin in Schizophrenia (NCT04177719) | National Institute of Mental Health and Neuro Sciences, India | 2019-11-08 |
| rTMS as a Probe of Episodic Memory Neurocircuitry in Schizophrenia (NCT04182113) | Indiana University | 2019-11-08 |
| Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY) (NCT04327843) | Case Western Reserve University | 2019-11-05 |
| The Effects of Simultaneous Training of Walking and Cognitive Tasks on Cognitive Functions of People With Schizophrenia (NCT04143308) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2019-11-05 |
| TMS in Treatment of Schizophrenia Negative Symptoms (NCT04268797) | Sveti Ivan Psychiatric Hospital | 2019-11-04 |
| Comparing Cognitive Remediation Approaches for Schizophrenia (NCT04123223) | Wesleyan University | 2019-11-01 |
| Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use (NCT03601026) | Nova Scotia Health Authority | 2019-11-01 |
| A Clinical Pharmacology Trial of Brexpiprazole Once-weekly (QW) Formulation Administered as Single and Multiple Oral Doses (NCT04118127) | Otsuka Pharmaceutical Co., Ltd. | 2019-10-17 |
| VR Therapy for Psychosis Negative Symptoms (V-NeST) (NCT03995420) | Institute of Psychiatry, London | 2019-10-15 |
| A Multiple Ascending Dose Trial of CVL-231 in Subjects With Schizophrenia (NCT04136873) | Cerevel Therapeutics, LLC | 2019-10-15 |
| A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia (NCT04092686) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2019-10-14 |
| High Intensity Interval Training in Severe Mental Illness (NCT03959735) | King's College London | 2019-10-10 |
| Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia (NCT04127058) | Vanda Pharmaceuticals | 2019-10-07 |
| Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects (NCT04025502) | ERP Biomarker Qualification Consortium | 2019-10-07 |
| Ocrelizumab for Psychosis by Autoimmunity (NCT03971487) | The Methodist Hospital Research Institute | 2019-10-01 |
| Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES) (NCT04143126) | University of Pittsburgh | 2019-10-01 |
| Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders (NCT03943537) | Mclean Hospital | 2019-10-01 |
| Oral Status of Patients Suffering From SCHIZophrenia Followed at Charles Perrens Hospital (NCT04191200) | Centre Hospitalier Charles Perrens, Bordeaux | 2019-09-24 |
| A Study of Paliperidone Palmitate 6-Month Formulation (NCT04072575) | Janssen Research & Development, LLC | 2019-09-19 |
| A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia (NCT04072354) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2019-09-17 |
| Motivational Interviewing in Patients With Schizophrenia (NCT04941352) | Pamukkale University | 2019-09-17 |
| Validating Reward-related Biomarkers (RTOC) (NCT04024371) | Maastricht University | 2019-09-16 |
| L-arginine Study for Persistent Symptoms of Schizophrenia (NCT04054973) | University of Massachusetts, Worcester | 2019-09-11 |
| rTMS on Mismatch Negativity of Schizophrenia (NCT04012684) | National Taiwan University Hospital | 2019-09-05 |
| Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics (NCT03790345) | Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara | 2019-09-03 |
| Trial of Stimulus-response Potentiation in Schizophrenia (NCT03892876) | Cairo University | 2019-09-01 |
| Effects of Integrated Moral Reasoning Development Intervention for Management of Violence in Schizophrenia (NCT05207319) | I-Shou University | 2019-09-01 |
| Ecologically Valid Virtual Tasks vs Paper-pencil Methods in Cognitive Rehabilitation in Patients With Schizophrenia and Depression (NCT04598906) | National Institute of Mental Health, Czech Republic | 2019-09-01 |
| ReMindCare App for Patients From First Episode of Psychosis Unit. (NCT03807388) | Instituto de Investigacion Sanitaria INCLIVA | 2019-09-01 |
| Repetitive Transcranial Magnetic Stimulation (rTMS) Self-Referential Processing (rTMS-SRP) (NCT04068857) | Indiana University | 2019-09-01 |
| Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia (NCT03788759) | Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara | 2019-09-01 |
| Sensitivity, Threshold, Tolerance and Pain Recognition in Schizophrenia Patients and Their Relatives. (NCT05345548) | HaEmek Medical Center, Israel | 2019-08-29 |
| RCT of tDCS Combined With Cognitive Training in Schizophrenia (NCT04870996) | CHAN SAU MAN, SANDRA | 2019-08-23 |
| Effects of Transcranial Direct Current Stimulation (tDCS) on Motor Function in Schizophrenia Patients and Individuals at Risk for Psychotic Onset (NCT04086160) | Dr WANG Shumei | 2019-08-22 |
| Walking for Health: an Intervention to Increase Physical Activity and Reduce Sedentary Behaviour in People With SMI (NCT04134871) | University of Ulster | 2019-08-22 |
| The Effect of Long-acting Antipsychotics on Schizophrenia Patients With Violence Risk (NCT04064476) | Huazhong University of Science and Technology | 2019-08-18 |
| Theta tACS During Working Memory Training: A Pilot Study of the Effects on Negative Symptoms of Schizophrenia (NCT04545294) | Tri-Service General Hospital (TSGH) | 2019-08-14 |